Free Trial
NYSEAMERICAN:MNI

McClatchy (MNI) Stock Price, News & Analysis

McClatchy logo
$0.75 0.00 (0.00%)
As of 02/13/2020

About McClatchy Stock (NYSEAMERICAN:MNI)

Key Stats

Today's Range
$0.75
$0.75
50-Day Range
$0.75
$0.75
52-Week Range
$0.29
$6.23
Volume
N/A
Average Volume
948,145 shs
Market Capitalization
$5.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MNI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McClatchy and its competitors with MarketBeat's FREE daily newsletter.

MNI Stock News Headlines

The McClatchy Company
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
New York Times Gives Hope Some Ink
Gannett Says Ad Recession Easing
See More Headlines

MNI Stock Analysis - Frequently Asked Questions

McClatchy's stock was trading at $0.75 at the beginning of the year. Since then, MNI shares have increased by 0.0% and is now trading at $0.75.

McClatchy Co (NYSEAMERICAN:MNI) issued its earnings results on Wednesday, November, 13th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.54) by $1.38. The company had revenue of $167.44 million for the quarter.

Shares of MNI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that McClatchy investors own include Sarepta Therapeutics (SRPT), Avino Silver & Gold Mines (ASM), AcelRx Pharmaceuticals (ACRX), OPKO Health (OPK), Pfizer (PFE), Protalix BioTherapeutics (PLX) and Arbutus Biopharma (ABUS).

Company Calendar

Last Earnings
11/13/2019
Today
7/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Publishing
Sub-Industry
Publishing
Current Symbol
NYSEAMERICAN:MNI
Previous Symbol
NYSE:MNI
CIK
1056087
Fax
N/A
Employees
3,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,930,000
Free Float
N/A
Market Cap
$5.95 million
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSEAMERICAN:MNI) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners